2m 2m 2m 2m 2m 2m 2m
LIMINATUS (LIMN)
NASDAQ
$0.10-$0.008 (-7.75%)
Price as of Jul 14, 2026 6:45 AM EDT- $6.7MMarket Cap
- -98.29%1-Year Change
- BiotechnologyIndustry
LIMINATUS (LIMN)
$0.10-$0.008 (-7.75%)
LIMN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.11 | ||
Change | -$0.006 (-5.24%) | ||
Open | $0.11 | ||
High | $0.11 | ||
Low | $0.10 | ||
Previous Close | $0.11 | ||
Volume | 3,553,650 | ||
30-Day Average Volume | 38,608,612 | ||
1-Week Change | -23.98% | ||
1-Month Change | -11.15% | ||
1-Year Change | -98.29% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 61.8M | ||
Total Assets | $2.8M | ||
Market Cap | $6.7M | ||
Enterprise Value | $6.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$1.1M | ||
Free Cash Flow | -$2.0M | ||
EBIT | -$1.1M | ||
EBITDA | -$1.1M | ||
Net Working Capital | -$110,877.00 | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -51 | ||
P/E | -4 | ||
PEG | -0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue